A prognostic nomogram integrating three molecular markers (EFNA1, CXCL8, PPP1R14A) with clinicopathological parameters (age, TNM stage) was developed to predict 3-/5-/8-year overall survival in cervical squamous cell carcinoma (Figure 12A). Here, CXCL8 is linked to cervical squamous cell carcinoma.